Search

Displaying results 5211 - 5220 of 8469 in total
  1. Drug

    GFT14

    go.drugbank.com/drugs/DB05061
    Experimental

    Orally absorbed GFT14 has absolutely no structural link with current treatments for dyslipidemia (statin or fibrate based). … GFT14 aims to target mixed dyslipidemia of type IIb (high levels of triglycerides and LDL-C) as one of the major indications of cardiometabolic disease.

  2. Drug

    E-6201

    go.drugbank.com/drugs/DB11687
    Investigational

    E6201 has been investigated for the treatment of Chronic Plaque Psoriasis.

  3. Drug

    Acetyl hexapeptide-3

    go.drugbank.com/drugs/DB11709
    Investigational

    Argireline has been used in trials studying the treatment of wrinkles.

  4. Drug

    Tegobuvir

    go.drugbank.com/drugs/DB11852
    Investigational

    Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic.

  5. Drug

    Pilsicainide

    go.drugbank.com/drugs/DB12712
    Investigational

    Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.

  6. Drug

    Olitigaltin

    go.drugbank.com/drugs/DB12895
    Investigational

    Olitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis.

  7. Drug

    Gacyclidine

    go.drugbank.com/drugs/DB13096
    Investigational

    Gacyclidine has been used in trials studying the treatment of Tinnitus.

  8. Drug

    Tropatepine

    go.drugbank.com/drugs/DB13252
    Experimental

    Tropatepine has been used in France for its antiparkinsons activities [A175024].

  9. Drug

    Vedroprevir

    go.drugbank.com/drugs/DB12037
    Investigational

    Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.

  10. Drug

    Milataxel

    go.drugbank.com/drugs/DB12334
    Investigational

    Milataxel has been used in trials studying the treatment of Mesothelioma.